[Analysis of risk factors of relapse after allogeneic hematopoietic stem cell transplantation in patients with t (8;21) acute myeloid leukemia] [0.03%]
t(8;21)急性髓系白血病异基因造血干细胞移植后复发风险因素分析
W W Guo,X Liu,A M Pang et al.
W W Guo et al.
Objective: To investigate the risk factors of relapse after allogeneic hematopoietic stem cell transplantation (allo-HSCT) in patients with t (8;21) acute myeloid leukemia (AML) . Methods: The clinical features of patients with t (8;21) AML...
[Clinical characteristics and prognosis of patients with Waldenström macroglobulinemia and its comparison with the Pivotal study] [0.03%]
[Waldenström巨球蛋白血症患者的临床特征及预后分析及其与Pivotal研究的对比]
Y Tao,S Wang,L Wang et al.
Y Tao et al.
Objective: This study aimed to summarize the clinical characteristics and prognosis of 108 patients with Waldenström macroglobulinemia (WM) in a single center and compare them with those of the Pivotal study with Bruton's tyrosine kinase i...
[Health-related quality of life and its associated variables in Chinese patients with Philadelphia-negative myeloproliferative neoplasms] [0.03%]
中国Ph染色体阴性骨髓增殖性肿瘤患者的健康相关生活质量及其影响因素
M Bao,D Y Shi,H X Shi et al.
M Bao et al.
Objectives: To explore health-related quality of life (HRQoL) and identify its associated variables in Chinese patients with Philadelphia-negative myeloproliferative neoplasms (MPNs) . Methods: In this cross-sectional study, anonymous quest...
[Expert consensus on laboratory standardized technical specifications for monitoring minimal residual disease using next-generation sequencing in multiple myeloma(2021)] [0.03%]
中国多发性骨髓瘤微小残留病监测二代测序实验室标准化技术规范专家共识(2021)
Laboratory Diagnosis Group, Chinese Society of Hematology, Chinese Medical Association;Plasma Cell Disease Group et al.
Laboratory Diagnosis Group et al.
[Reflections on the innovative research and development of hematologic oncology drugs under the new situation] [0.03%]
新形势下的血液系统肿瘤药物创新研发思考
L Tang,X M Chen,L M Zou et al.
L Tang et al.
[Prospects of individualized diagnosis and treatment of primary immune thrombocytopenia in the era of new drugs] [0.03%]
新药时代下特发性血小板减少性紫癜的个体化诊治展望
L L Huang,H Mei
L L Huang
B K Yang,T Wu,Y Q An et al.
B K Yang et al.
[Systemic light chain amyloidosis with the manifestation of recurrent spontaneous liver rupture: a case report] [0.03%]
系统性轻链型淀粉样变性合并自发性肝破裂1例报告
F Zhi,Y Y Wang,Y P Ma et al.
F Zhi et al.
[A case of 12p13.2 heterozygous gene deletion syndrome: congenital thrombocytopenia, ectrodactyly, and tooth deformities] [0.03%]
[12p13.2杂合性基因缺失综合征一例：先天血小板减少、分裂手和牙齿畸形]
Y Xu,Y F Chen,R F Fu et al.
Y Xu et al.